PR Newswire

Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare ConferenceJanuary 12, 2026
SHANGHAI and BOSTON, Jan. 11, 2026 /PRNewswire/ — Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a…
REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy ProgramJanuary 11, 2026
New Phase I/II RGX-202 functional data demonstrates long-term, durable treatment effect at pivotal dose at…
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 ResultsJanuary 11, 2026
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in…
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare ConferenceJanuary 11, 2026
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2026 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading…
Piramal Pharma erzielt deutliche Punktzahlsteigerung bei der Bewertung der Unternehmensnachhaltigkeit (CSA) von S&P Global für 2025January 10, 2026
Der S&P Global CSA ist ein jährlicher Test, der die Nachhaltigkeitspraktiken Tausender Unternehmen bewertet. Er…
Ribo Life Science (06938.HK) cotiza con éxito en la Bolsa de Valores de Hong KongJanuary 10, 2026
HONG KONG, 10 de enero de 2026 /PRNewswire/ — Ribo Life Science Co., Ltd. (“Ribo”…
Ribo Life Science (06938.HK) erfolgreich am Main Board der Hongkonger Börse notiertJanuary 10, 2026
HONGKONG, 10. Januar 2026 /PRNewswire/ — Ribo Life Science Co., Ltd. („Ribo” oder das „Unternehmen”,…
Ribo Life Science (06938.HK) réussit son inscription au marché principal de la Bourse de Hong KongJanuary 10, 2026
HONG KONG, 10 janvier 2026 /PRNewswire/ — Ribo Life Science Co, Ltd. (« Ribo » ou la…
Piramal Pharma obtient une augmentation notable de son score lors de l’évaluation mondiale de la durabilité des entreprises (CSA) de 2025 de S&PJanuary 10, 2026
Le S&P Global CSA est un test annuel qui évalue les pratiques de développement durable…
Ascentiz Unveiled Modular Designed Exoskeleton at CES 2026: A Technical Deep Dive into Biomechanical IntelligenceJanuary 9, 2026
The world’s first modular exoskeleton combines quasi-direct-drive hip and cable-drive knee technologies for natural, powerful…
Phanes Therapeutics Announces Positive Phase 2 Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026January 9, 2026
SAN DIEGO, Jan. 9, 2026 /PRNewswire/ — Data presented at ASCO GI 2026 show spevatamig,…
Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)January 9, 2026
The S&P Global CSA is an annual test that evaluates the sustainability practices of thousands…
Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)January 9, 2026
The S&P Global CSA is an annual test that evaluates the sustainability practices of thousands…
M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bioJanuary 9, 2026
LONDON, Jan. 9, 2026 /PRNewswire/ — M&G Investments (M&G) today announces that it has led…
M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bioJanuary 9, 2026
LONDON, Jan. 9, 2026 /PRNewswire/ — M&G Investments (M&G) today announces that it has led…
Pierre Fabre Laboratories und Iktos kündigen eine integrierte KI-gestützte Zusammenarbeit bei der Arzneimittelentdeckung in der Onkologie anJanuary 9, 2026
CASTRES, Frankreich und PARIS, 9. Januar 2026 /PRNewswire/ — Pierre Fabre Laboratories und Iktos, ein weltweit führender…
Human Microbiome Drugs Market worth $2.13 billion by 2031 | MarketsandMarkets™January 9, 2026
DELRAY BEACH, Fla., Jan. 9, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Human Microbiome Drugs Market is…
Continued Zenocutuzumab Treatment Beyond Progression Shows Benefit in Patients with NRG1+ Pancreatic Cancer and Cholangiocarcinoma: New Results from the eNRGy Trial Presented at ASCO GIJanuary 9, 2026
LEXINGTON, Mass., Jan. 9, 2026 /PRNewswire/ — Partner Therapeutics, Inc. (PTx), a private, fully integrated…
Prescient Healthcare Group Acquires UptakeJanuary 9, 2026
Prescient acquires Uptake, bringing together two like-minded organizations with a focus on exceptional client delivery…
New Partnership Between PureWay and PPSWG Aims to Transform How America Manages Pharmaceutical WasteJanuary 9, 2026
HOUSTON, Jan. 9, 2026 /PRNewswire/ — In a move set to strengthen the nation’s approach…